SCHEMBL24074474

SCHEMBL24074474

O=Nc1cnc(NC(=O)c2ccccc2C2CC2)s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 3/20 0.41
▸ NPC1 O15118 4/20 0.40
▸ RAB9A P51151 4/20 0.40
▸ POLB P06746 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ CCNE1 P24864 5/20 0.39
▸ CDK2 P24941 5/20 0.39
▸ CDK5 Q00535 5/20 0.39
▸ ALDH1A1 P00352 5/20 0.39
▸ MAPT P10636 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ CDK5R1 Q15078 1/20 0.38
▸ PKM P14618 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ TP53 P04637 2/20 0.37
▸ MLNR O43193 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27134411 0.81 STAT3 (0.40) STAT3NPC1RAB9APOLBMEN1
SCHEMBL19632762 0.81 STAT3 (0.61) STAT3NPC1RAB9APOLBMEN1
SCHEMBL27135218 0.81 CYP1A2 (0.55) STAT3NPC1RAB9APOLBMEN1
SCHEMBL24074515 0.80 KAT2B (0.44) STAT3NPC1RAB9APOLBMEN1
SCHEMBL24073670 0.80 RXFP1 (0.46) NPC1RAB9AALDH1A1SMN1; SMN2HSD17B10
SCHEMBL24072396 0.80 STAT3 (0.44) STAT3NPC1RAB9APOLBMEN1
SCHEMBL27134429 0.80 SMN1; SMN2 (0.50) POLBMEN1KMT2AALDH1A1MAPT
SCHEMBL24074429 0.80 RAB9A (0.52) STAT3NPC1RAB9APOLBALDH1A1
SCHEMBL24074140 0.80 NPC1 (0.56) STAT3NPC1RAB9APOLBMEN1
SCHEMBL27134428 0.80 NPC1 (0.62) STAT3NPC1RAB9APOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 — — US disclosed
WO-2021239117-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI) , INC. (CN) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 STAT3 3224/4885NPC1 3949/4885RAB9A 3280/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 STAT3 3224/4885NPC1 3949/4885RAB9A 3280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback